nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—coronary artery disease—atherosclerosis	0.387	1	CtDrD
Olmesartan—AGTR1—atherosclerosis	0.227	1	CbGaD
Olmesartan—SLCO1B3—Rosuvastatin—atherosclerosis	0.0441	0.152	CbGbCtD
Olmesartan—SLCO1B3—Pravastatin—atherosclerosis	0.0401	0.138	CbGbCtD
Olmesartan—SLCO1B1—Ezetimibe—atherosclerosis	0.0257	0.0883	CbGbCtD
Olmesartan—SLCO1B1—Rosuvastatin—atherosclerosis	0.0257	0.0883	CbGbCtD
Olmesartan—SLCO1B1—Simvastatin—atherosclerosis	0.0239	0.0821	CbGbCtD
Olmesartan—SLCO1B1—Lovastatin—atherosclerosis	0.0234	0.0803	CbGbCtD
Olmesartan—SLCO1B1—Pravastatin—atherosclerosis	0.0234	0.0803	CbGbCtD
Olmesartan—ABCC2—Ezetimibe—atherosclerosis	0.0226	0.0776	CbGbCtD
Olmesartan—ABCC2—Simvastatin—atherosclerosis	0.021	0.0721	CbGbCtD
Olmesartan—ABCC2—Pravastatin—atherosclerosis	0.0205	0.0706	CbGbCtD
Olmesartan—ABCC2—Lovastatin—atherosclerosis	0.0205	0.0706	CbGbCtD
Olmesartan—Azilsartan medoxomil—AGTR1—atherosclerosis	0.000501	0.179	CrCbGaD
Olmesartan—Forasartan—AGTR1—atherosclerosis	0.000465	0.167	CrCbGaD
Olmesartan—AGTR1—artery—atherosclerosis	0.000415	0.217	CbGeAlD
Olmesartan—AGTR1—endothelium—atherosclerosis	0.000351	0.183	CbGeAlD
Olmesartan—AGTR1—blood vessel—atherosclerosis	0.000324	0.169	CbGeAlD
Olmesartan—Tasosartan—AGTR1—atherosclerosis	0.000282	0.101	CrCbGaD
Olmesartan—Irbesartan—EDNRA—atherosclerosis	0.000278	0.0995	CrCbGaD
Olmesartan—Valsartan—AGTR1—atherosclerosis	0.000245	0.0876	CrCbGaD
Olmesartan—Telmisartan—AGTR1—atherosclerosis	0.00023	0.0824	CrCbGaD
Olmesartan—Candesartan—AGTR1—atherosclerosis	0.000185	0.0664	CrCbGaD
Olmesartan—Irbesartan—AGTR1—atherosclerosis	0.000185	0.0664	CrCbGaD
Olmesartan—AGTR1—connective tissue—atherosclerosis	0.000166	0.0867	CbGeAlD
Olmesartan—Sinusitis—Simvastatin—atherosclerosis	0.000159	0.00251	CcSEcCtD
Olmesartan—Pharyngitis—Ezetimibe—atherosclerosis	0.000159	0.0025	CcSEcCtD
Olmesartan—Erectile dysfunction—Pravastatin—atherosclerosis	0.000158	0.0025	CcSEcCtD
Olmesartan—Oedema peripheral—Ezetimibe—atherosclerosis	0.000157	0.00248	CcSEcCtD
Olmesartan—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000157	0.00247	CcSEcCtD
Olmesartan—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000157	0.00247	CcSEcCtD
Olmesartan—Angioedema—Rosuvastatin—atherosclerosis	0.000153	0.00241	CcSEcCtD
Olmesartan—Jaundice—Niacin—atherosclerosis	0.000152	0.00239	CcSEcCtD
Olmesartan—Jaundice—Pravastatin—atherosclerosis	0.00015	0.00235	CcSEcCtD
Olmesartan—Urinary tract infection—Pravastatin—atherosclerosis	0.000149	0.00235	CcSEcCtD
Olmesartan—SLCO1B3—liver—atherosclerosis	0.000147	0.0769	CbGeAlD
Olmesartan—Cough—Rosuvastatin—atherosclerosis	0.000146	0.0023	CcSEcCtD
Olmesartan—Angiopathy—Ezetimibe—atherosclerosis	0.000145	0.00228	CcSEcCtD
Olmesartan—Telmisartan—PPARG—atherosclerosis	0.000145	0.0519	CrCbGaD
Olmesartan—AGTR1—cardiovascular system—atherosclerosis	0.000144	0.0754	CbGeAlD
Olmesartan—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000144	0.00227	CcSEcCtD
Olmesartan—Sinusitis—Pravastatin—atherosclerosis	0.000144	0.00227	CcSEcCtD
Olmesartan—Alopecia—Lovastatin—atherosclerosis	0.000144	0.00227	CcSEcCtD
Olmesartan—Myalgia—Rosuvastatin—atherosclerosis	0.000142	0.00224	CcSEcCtD
Olmesartan—Arthralgia—Rosuvastatin—atherosclerosis	0.000142	0.00224	CcSEcCtD
Olmesartan—Alopecia—Ezetimibe—atherosclerosis	0.000141	0.00222	CcSEcCtD
Olmesartan—Rhinitis—Niacin—atherosclerosis	0.00014	0.00221	CcSEcCtD
Olmesartan—Mental disorder—Ezetimibe—atherosclerosis	0.00014	0.0022	CcSEcCtD
Olmesartan—Malnutrition—Ezetimibe—atherosclerosis	0.000139	0.00219	CcSEcCtD
Olmesartan—Rhinitis—Pravastatin—atherosclerosis	0.000138	0.00217	CcSEcCtD
Olmesartan—Oedema peripheral—Niacin—atherosclerosis	0.000138	0.00217	CcSEcCtD
Olmesartan—Back pain—Lovastatin—atherosclerosis	0.000137	0.00216	CcSEcCtD
Olmesartan—Pharyngitis—Pravastatin—atherosclerosis	0.000137	0.00215	CcSEcCtD
Olmesartan—Muscle spasms—Lovastatin—atherosclerosis	0.000136	0.00215	CcSEcCtD
Olmesartan—Infection—Rosuvastatin—atherosclerosis	0.000136	0.00214	CcSEcCtD
Olmesartan—Alopecia—Simvastatin—atherosclerosis	0.000135	0.00212	CcSEcCtD
Olmesartan—Back pain—Ezetimibe—atherosclerosis	0.000135	0.00212	CcSEcCtD
Olmesartan—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000134	0.00211	CcSEcCtD
Olmesartan—Muscle spasms—Ezetimibe—atherosclerosis	0.000134	0.0021	CcSEcCtD
Olmesartan—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000134	0.0021	CcSEcCtD
Olmesartan—Vision blurred—Lovastatin—atherosclerosis	0.000134	0.0021	CcSEcCtD
Olmesartan—Mental disorder—Simvastatin—atherosclerosis	0.000133	0.0021	CcSEcCtD
Olmesartan—Ill-defined disorder—Lovastatin—atherosclerosis	0.000132	0.00207	CcSEcCtD
Olmesartan—Angioedema—Lovastatin—atherosclerosis	0.00013	0.00204	CcSEcCtD
Olmesartan—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000129	0.00203	CcSEcCtD
Olmesartan—Anaemia—Ezetimibe—atherosclerosis	0.000129	0.00202	CcSEcCtD
Olmesartan—Malaise—Lovastatin—atherosclerosis	0.000128	0.00201	CcSEcCtD
Olmesartan—Muscle spasms—Simvastatin—atherosclerosis	0.000128	0.00201	CcSEcCtD
Olmesartan—Vertigo—Lovastatin—atherosclerosis	0.000127	0.00201	CcSEcCtD
Olmesartan—AGTR1—adipose tissue—atherosclerosis	0.000127	0.0665	CbGeAlD
Olmesartan—Angioedema—Ezetimibe—atherosclerosis	0.000127	0.002	CcSEcCtD
Olmesartan—Angiopathy—Niacin—atherosclerosis	0.000127	0.002	CcSEcCtD
Olmesartan—Leukopenia—Lovastatin—atherosclerosis	0.000127	0.002	CcSEcCtD
Olmesartan—Malaise—Ezetimibe—atherosclerosis	0.000125	0.00197	CcSEcCtD
Olmesartan—Vision blurred—Simvastatin—atherosclerosis	0.000125	0.00197	CcSEcCtD
Olmesartan—Arrhythmia—Niacin—atherosclerosis	0.000125	0.00197	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000124	0.00196	CcSEcCtD
Olmesartan—Alopecia—Niacin—atherosclerosis	0.000124	0.00195	CcSEcCtD
Olmesartan—Insomnia—Rosuvastatin—atherosclerosis	0.000124	0.00194	CcSEcCtD
Olmesartan—Ill-defined disorder—Simvastatin—atherosclerosis	0.000123	0.00194	CcSEcCtD
Olmesartan—Arrhythmia—Pravastatin—atherosclerosis	0.000123	0.00194	CcSEcCtD
Olmesartan—Palpitations—Ezetimibe—atherosclerosis	0.000123	0.00193	CcSEcCtD
Olmesartan—Anaemia—Simvastatin—atherosclerosis	0.000123	0.00193	CcSEcCtD
Olmesartan—Malnutrition—Niacin—atherosclerosis	0.000122	0.00192	CcSEcCtD
Olmesartan—Alopecia—Pravastatin—atherosclerosis	0.000122	0.00192	CcSEcCtD
Olmesartan—Cough—Ezetimibe—atherosclerosis	0.000121	0.00191	CcSEcCtD
Olmesartan—Angioedema—Simvastatin—atherosclerosis	0.000121	0.00191	CcSEcCtD
Olmesartan—Chest pain—Lovastatin—atherosclerosis	0.000121	0.0019	CcSEcCtD
Olmesartan—Myalgia—Lovastatin—atherosclerosis	0.000121	0.0019	CcSEcCtD
Olmesartan—Arthralgia—Lovastatin—atherosclerosis	0.000121	0.0019	CcSEcCtD
Olmesartan—Anxiety—Lovastatin—atherosclerosis	0.00012	0.00189	CcSEcCtD
Olmesartan—Dyspepsia—Rosuvastatin—atherosclerosis	0.00012	0.00189	CcSEcCtD
Olmesartan—Malaise—Simvastatin—atherosclerosis	0.00012	0.00188	CcSEcCtD
Olmesartan—Losartan—AGTR1—atherosclerosis	0.000119	0.0428	CrCbGaD
Olmesartan—Discomfort—Lovastatin—atherosclerosis	0.000119	0.00188	CcSEcCtD
Olmesartan—Vertigo—Simvastatin—atherosclerosis	0.000119	0.00188	CcSEcCtD
Olmesartan—Leukopenia—Simvastatin—atherosclerosis	0.000119	0.00187	CcSEcCtD
Olmesartan—Chest pain—Ezetimibe—atherosclerosis	0.000118	0.00186	CcSEcCtD
Olmesartan—Arthralgia—Ezetimibe—atherosclerosis	0.000118	0.00186	CcSEcCtD
Olmesartan—Myalgia—Ezetimibe—atherosclerosis	0.000118	0.00186	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000118	0.00185	CcSEcCtD
Olmesartan—Muscle spasms—Niacin—atherosclerosis	0.000117	0.00184	CcSEcCtD
Olmesartan—Discomfort—Ezetimibe—atherosclerosis	0.000117	0.00184	CcSEcCtD
Olmesartan—Pain—Rosuvastatin—atherosclerosis	0.000117	0.00184	CcSEcCtD
Olmesartan—Constipation—Rosuvastatin—atherosclerosis	0.000117	0.00184	CcSEcCtD
Olmesartan—Anaphylactic shock—Lovastatin—atherosclerosis	0.000116	0.00182	CcSEcCtD
Olmesartan—Muscle spasms—Pravastatin—atherosclerosis	0.000115	0.00181	CcSEcCtD
Olmesartan—Infection—Lovastatin—atherosclerosis	0.000115	0.00181	CcSEcCtD
Olmesartan—Vision blurred—Niacin—atherosclerosis	0.000115	0.00181	CcSEcCtD
Olmesartan—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000114	0.00179	CcSEcCtD
Olmesartan—Thrombocytopenia—Lovastatin—atherosclerosis	0.000113	0.00178	CcSEcCtD
Olmesartan—Vision blurred—Pravastatin—atherosclerosis	0.000113	0.00178	CcSEcCtD
Olmesartan—Chest pain—Simvastatin—atherosclerosis	0.000113	0.00178	CcSEcCtD
Olmesartan—Myalgia—Simvastatin—atherosclerosis	0.000113	0.00178	CcSEcCtD
Olmesartan—Arthralgia—Simvastatin—atherosclerosis	0.000113	0.00178	CcSEcCtD
Olmesartan—Infection—Ezetimibe—atherosclerosis	0.000113	0.00178	CcSEcCtD
Olmesartan—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000113	0.00177	CcSEcCtD
Olmesartan—Anxiety—Simvastatin—atherosclerosis	0.000113	0.00177	CcSEcCtD
Olmesartan—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000112	0.00176	CcSEcCtD
Olmesartan—Discomfort—Simvastatin—atherosclerosis	0.000112	0.00176	CcSEcCtD
Olmesartan—Nervous system disorder—Ezetimibe—atherosclerosis	0.000111	0.00175	CcSEcCtD
Olmesartan—Angioedema—Niacin—atherosclerosis	0.000111	0.00175	CcSEcCtD
Olmesartan—Ill-defined disorder—Pravastatin—atherosclerosis	0.000111	0.00175	CcSEcCtD
Olmesartan—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000111	0.00175	CcSEcCtD
Olmesartan—Anaemia—Pravastatin—atherosclerosis	0.000111	0.00174	CcSEcCtD
Olmesartan—Anorexia—Lovastatin—atherosclerosis	0.00011	0.00174	CcSEcCtD
Olmesartan—Skin disorder—Ezetimibe—atherosclerosis	0.00011	0.00174	CcSEcCtD
Olmesartan—Angioedema—Pravastatin—atherosclerosis	0.00011	0.00172	CcSEcCtD
Olmesartan—Vertigo—Niacin—atherosclerosis	0.000109	0.00172	CcSEcCtD
Olmesartan—Syncope—Niacin—atherosclerosis	0.000109	0.00172	CcSEcCtD
Olmesartan—Leukopenia—Niacin—atherosclerosis	0.000109	0.00172	CcSEcCtD
Olmesartan—Urticaria—Rosuvastatin—atherosclerosis	0.000108	0.00171	CcSEcCtD
Olmesartan—Anaphylactic shock—Simvastatin—atherosclerosis	0.000108	0.0017	CcSEcCtD
Olmesartan—Oedema—Simvastatin—atherosclerosis	0.000108	0.0017	CcSEcCtD
Olmesartan—Malaise—Pravastatin—atherosclerosis	0.000108	0.0017	CcSEcCtD
Olmesartan—Abdominal pain—Rosuvastatin—atherosclerosis	0.000108	0.0017	CcSEcCtD
Olmesartan—Vertigo—Pravastatin—atherosclerosis	0.000108	0.0017	CcSEcCtD
Olmesartan—Palpitations—Niacin—atherosclerosis	0.000108	0.00169	CcSEcCtD
Olmesartan—Infection—Simvastatin—atherosclerosis	0.000108	0.00169	CcSEcCtD
Olmesartan—Leukopenia—Pravastatin—atherosclerosis	0.000107	0.00169	CcSEcCtD
Olmesartan—Loss of consciousness—Niacin—atherosclerosis	0.000107	0.00169	CcSEcCtD
Olmesartan—Cough—Niacin—atherosclerosis	0.000106	0.00167	CcSEcCtD
Olmesartan—Thrombocytopenia—Simvastatin—atherosclerosis	0.000106	0.00167	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000105	0.00166	CcSEcCtD
Olmesartan—Insomnia—Lovastatin—atherosclerosis	0.000105	0.00165	CcSEcCtD
Olmesartan—Cough—Pravastatin—atherosclerosis	0.000105	0.00165	CcSEcCtD
Olmesartan—Myalgia—Niacin—atherosclerosis	0.000104	0.00163	CcSEcCtD
Olmesartan—Arthralgia—Niacin—atherosclerosis	0.000104	0.00163	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000103	0.00163	CcSEcCtD
Olmesartan—Anorexia—Simvastatin—atherosclerosis	0.000103	0.00162	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000103	0.00162	CcSEcCtD
Olmesartan—Insomnia—Ezetimibe—atherosclerosis	0.000103	0.00162	CcSEcCtD
Olmesartan—Myalgia—Pravastatin—atherosclerosis	0.000102	0.00161	CcSEcCtD
Olmesartan—Arthralgia—Pravastatin—atherosclerosis	0.000102	0.00161	CcSEcCtD
Olmesartan—Chest pain—Pravastatin—atherosclerosis	0.000102	0.00161	CcSEcCtD
Olmesartan—Dyspepsia—Lovastatin—atherosclerosis	0.000102	0.0016	CcSEcCtD
Olmesartan—Anxiety—Pravastatin—atherosclerosis	0.000102	0.0016	CcSEcCtD
Olmesartan—Discomfort—Pravastatin—atherosclerosis	0.000101	0.00159	CcSEcCtD
Olmesartan—Decreased appetite—Lovastatin—atherosclerosis	0.000101	0.00158	CcSEcCtD
Olmesartan—Dyspepsia—Ezetimibe—atherosclerosis	9.99e-05	0.00157	CcSEcCtD
Olmesartan—Fatigue—Lovastatin—atherosclerosis	9.98e-05	0.00157	CcSEcCtD
Olmesartan—Oedema—Niacin—atherosclerosis	9.94e-05	0.00156	CcSEcCtD
Olmesartan—Anaphylactic shock—Niacin—atherosclerosis	9.94e-05	0.00156	CcSEcCtD
Olmesartan—Pain—Lovastatin—atherosclerosis	9.9e-05	0.00156	CcSEcCtD
Olmesartan—Constipation—Lovastatin—atherosclerosis	9.9e-05	0.00156	CcSEcCtD
Olmesartan—Decreased appetite—Ezetimibe—atherosclerosis	9.87e-05	0.00155	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Simvastatin—atherosclerosis	9.86e-05	0.00155	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	9.8e-05	0.00154	CcSEcCtD
Olmesartan—Asthenia—Rosuvastatin—atherosclerosis	9.8e-05	0.00154	CcSEcCtD
Olmesartan—Insomnia—Simvastatin—atherosclerosis	9.79e-05	0.00154	CcSEcCtD
Olmesartan—Oedema—Pravastatin—atherosclerosis	9.79e-05	0.00154	CcSEcCtD
Olmesartan—Anaphylactic shock—Pravastatin—atherosclerosis	9.79e-05	0.00154	CcSEcCtD
Olmesartan—Fatigue—Ezetimibe—atherosclerosis	9.79e-05	0.00154	CcSEcCtD
Olmesartan—Shock—Niacin—atherosclerosis	9.78e-05	0.00154	CcSEcCtD
Olmesartan—Infection—Pravastatin—atherosclerosis	9.72e-05	0.00153	CcSEcCtD
Olmesartan—Pain—Ezetimibe—atherosclerosis	9.71e-05	0.00153	CcSEcCtD
Olmesartan—Constipation—Ezetimibe—atherosclerosis	9.71e-05	0.00153	CcSEcCtD
Olmesartan—Tachycardia—Niacin—atherosclerosis	9.7e-05	0.00153	CcSEcCtD
Olmesartan—Pruritus—Rosuvastatin—atherosclerosis	9.66e-05	0.00152	CcSEcCtD
Olmesartan—Skin disorder—Niacin—atherosclerosis	9.65e-05	0.00152	CcSEcCtD
Olmesartan—Hyperhidrosis—Niacin—atherosclerosis	9.61e-05	0.00151	CcSEcCtD
Olmesartan—Thrombocytopenia—Pravastatin—atherosclerosis	9.58e-05	0.00151	CcSEcCtD
Olmesartan—Feeling abnormal—Lovastatin—atherosclerosis	9.54e-05	0.0015	CcSEcCtD
Olmesartan—Dyspepsia—Simvastatin—atherosclerosis	9.53e-05	0.0015	CcSEcCtD
Olmesartan—Anorexia—Niacin—atherosclerosis	9.47e-05	0.00149	CcSEcCtD
Olmesartan—Gastrointestinal pain—Lovastatin—atherosclerosis	9.46e-05	0.00149	CcSEcCtD
Olmesartan—Hyperhidrosis—Pravastatin—atherosclerosis	9.46e-05	0.00149	CcSEcCtD
Olmesartan—Decreased appetite—Simvastatin—atherosclerosis	9.41e-05	0.00148	CcSEcCtD
Olmesartan—Feeling abnormal—Ezetimibe—atherosclerosis	9.35e-05	0.00147	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Simvastatin—atherosclerosis	9.34e-05	0.00147	CcSEcCtD
Olmesartan—Diarrhoea—Rosuvastatin—atherosclerosis	9.34e-05	0.00147	CcSEcCtD
Olmesartan—Fatigue—Simvastatin—atherosclerosis	9.33e-05	0.00147	CcSEcCtD
Olmesartan—Anorexia—Pravastatin—atherosclerosis	9.33e-05	0.00147	CcSEcCtD
Olmesartan—Hypotension—Niacin—atherosclerosis	9.29e-05	0.00146	CcSEcCtD
Olmesartan—Gastrointestinal pain—Ezetimibe—atherosclerosis	9.28e-05	0.00146	CcSEcCtD
Olmesartan—Pain—Simvastatin—atherosclerosis	9.26e-05	0.00146	CcSEcCtD
Olmesartan—Constipation—Simvastatin—atherosclerosis	9.26e-05	0.00146	CcSEcCtD
Olmesartan—Urticaria—Lovastatin—atherosclerosis	9.19e-05	0.00145	CcSEcCtD
Olmesartan—Body temperature increased—Lovastatin—atherosclerosis	9.15e-05	0.00144	CcSEcCtD
Olmesartan—Abdominal pain—Lovastatin—atherosclerosis	9.15e-05	0.00144	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Niacin—atherosclerosis	9.06e-05	0.00143	CcSEcCtD
Olmesartan—Dizziness—Rosuvastatin—atherosclerosis	9.03e-05	0.00142	CcSEcCtD
Olmesartan—Urticaria—Ezetimibe—atherosclerosis	9.02e-05	0.00142	CcSEcCtD
Olmesartan—Insomnia—Niacin—atherosclerosis	8.99e-05	0.00142	CcSEcCtD
Olmesartan—Abdominal pain—Ezetimibe—atherosclerosis	8.97e-05	0.00141	CcSEcCtD
Olmesartan—Body temperature increased—Ezetimibe—atherosclerosis	8.97e-05	0.00141	CcSEcCtD
Olmesartan—AGTR1—liver—atherosclerosis	8.93e-05	0.0467	CbGeAlD
Olmesartan—Feeling abnormal—Simvastatin—atherosclerosis	8.92e-05	0.0014	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Pravastatin—atherosclerosis	8.92e-05	0.0014	CcSEcCtD
Olmesartan—Gastrointestinal pain—Simvastatin—atherosclerosis	8.85e-05	0.00139	CcSEcCtD
Olmesartan—Insomnia—Pravastatin—atherosclerosis	8.85e-05	0.00139	CcSEcCtD
Olmesartan—Dyspepsia—Niacin—atherosclerosis	8.75e-05	0.00138	CcSEcCtD
Olmesartan—Decreased appetite—Niacin—atherosclerosis	8.64e-05	0.00136	CcSEcCtD
Olmesartan—Dyspepsia—Pravastatin—atherosclerosis	8.61e-05	0.00136	CcSEcCtD
Olmesartan—Rash—Rosuvastatin—atherosclerosis	8.61e-05	0.00136	CcSEcCtD
Olmesartan—Dermatitis—Rosuvastatin—atherosclerosis	8.6e-05	0.00135	CcSEcCtD
Olmesartan—Urticaria—Simvastatin—atherosclerosis	8.6e-05	0.00135	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Niacin—atherosclerosis	8.58e-05	0.00135	CcSEcCtD
Olmesartan—Body temperature increased—Simvastatin—atherosclerosis	8.56e-05	0.00135	CcSEcCtD
Olmesartan—Abdominal pain—Simvastatin—atherosclerosis	8.56e-05	0.00135	CcSEcCtD
Olmesartan—Headache—Rosuvastatin—atherosclerosis	8.55e-05	0.00135	CcSEcCtD
Olmesartan—SLCO1B1—liver—atherosclerosis	8.51e-05	0.0445	CbGeAlD
Olmesartan—Decreased appetite—Pravastatin—atherosclerosis	8.51e-05	0.00134	CcSEcCtD
Olmesartan—Pain—Niacin—atherosclerosis	8.5e-05	0.00134	CcSEcCtD
Olmesartan—Fatigue—Pravastatin—atherosclerosis	8.44e-05	0.00133	CcSEcCtD
Olmesartan—Pain—Pravastatin—atherosclerosis	8.37e-05	0.00132	CcSEcCtD
Olmesartan—Constipation—Pravastatin—atherosclerosis	8.37e-05	0.00132	CcSEcCtD
Olmesartan—Asthenia—Lovastatin—atherosclerosis	8.3e-05	0.00131	CcSEcCtD
Olmesartan—Pruritus—Lovastatin—atherosclerosis	8.19e-05	0.00129	CcSEcCtD
Olmesartan—Asthenia—Ezetimibe—atherosclerosis	8.14e-05	0.00128	CcSEcCtD
Olmesartan—Gastrointestinal pain—Niacin—atherosclerosis	8.13e-05	0.00128	CcSEcCtD
Olmesartan—Nausea—Rosuvastatin—atherosclerosis	8.11e-05	0.00128	CcSEcCtD
Olmesartan—Feeling abnormal—Pravastatin—atherosclerosis	8.06e-05	0.00127	CcSEcCtD
Olmesartan—Pruritus—Ezetimibe—atherosclerosis	8.03e-05	0.00126	CcSEcCtD
Olmesartan—Gastrointestinal pain—Pravastatin—atherosclerosis	8e-05	0.00126	CcSEcCtD
Olmesartan—Diarrhoea—Lovastatin—atherosclerosis	7.92e-05	0.00125	CcSEcCtD
Olmesartan—Urticaria—Niacin—atherosclerosis	7.9e-05	0.00124	CcSEcCtD
Olmesartan—Abdominal pain—Niacin—atherosclerosis	7.86e-05	0.00124	CcSEcCtD
Olmesartan—Body temperature increased—Niacin—atherosclerosis	7.86e-05	0.00124	CcSEcCtD
Olmesartan—Urticaria—Pravastatin—atherosclerosis	7.77e-05	0.00122	CcSEcCtD
Olmesartan—Asthenia—Simvastatin—atherosclerosis	7.77e-05	0.00122	CcSEcCtD
Olmesartan—Diarrhoea—Ezetimibe—atherosclerosis	7.77e-05	0.00122	CcSEcCtD
Olmesartan—Abdominal pain—Pravastatin—atherosclerosis	7.74e-05	0.00122	CcSEcCtD
Olmesartan—Body temperature increased—Pravastatin—atherosclerosis	7.74e-05	0.00122	CcSEcCtD
Olmesartan—Pruritus—Simvastatin—atherosclerosis	7.66e-05	0.00121	CcSEcCtD
Olmesartan—Dizziness—Lovastatin—atherosclerosis	7.65e-05	0.0012	CcSEcCtD
Olmesartan—Dizziness—Ezetimibe—atherosclerosis	7.51e-05	0.00118	CcSEcCtD
Olmesartan—Diarrhoea—Simvastatin—atherosclerosis	7.41e-05	0.00117	CcSEcCtD
Olmesartan—Vomiting—Lovastatin—atherosclerosis	7.36e-05	0.00116	CcSEcCtD
Olmesartan—Rash—Lovastatin—atherosclerosis	7.3e-05	0.00115	CcSEcCtD
Olmesartan—Dermatitis—Lovastatin—atherosclerosis	7.29e-05	0.00115	CcSEcCtD
Olmesartan—Headache—Lovastatin—atherosclerosis	7.25e-05	0.00114	CcSEcCtD
Olmesartan—Vomiting—Ezetimibe—atherosclerosis	7.22e-05	0.00114	CcSEcCtD
Olmesartan—Dizziness—Simvastatin—atherosclerosis	7.16e-05	0.00113	CcSEcCtD
Olmesartan—Rash—Ezetimibe—atherosclerosis	7.16e-05	0.00113	CcSEcCtD
Olmesartan—Dermatitis—Ezetimibe—atherosclerosis	7.15e-05	0.00113	CcSEcCtD
Olmesartan—Asthenia—Niacin—atherosclerosis	7.13e-05	0.00112	CcSEcCtD
Olmesartan—Headache—Ezetimibe—atherosclerosis	7.11e-05	0.00112	CcSEcCtD
Olmesartan—Pruritus—Niacin—atherosclerosis	7.03e-05	0.00111	CcSEcCtD
Olmesartan—Asthenia—Pravastatin—atherosclerosis	7.02e-05	0.00111	CcSEcCtD
Olmesartan—Pruritus—Pravastatin—atherosclerosis	6.92e-05	0.00109	CcSEcCtD
Olmesartan—Losartan—ACE—atherosclerosis	6.9e-05	0.0247	CrCbGaD
Olmesartan—Vomiting—Simvastatin—atherosclerosis	6.88e-05	0.00108	CcSEcCtD
Olmesartan—Nausea—Lovastatin—atherosclerosis	6.87e-05	0.00108	CcSEcCtD
Olmesartan—Rash—Simvastatin—atherosclerosis	6.82e-05	0.00107	CcSEcCtD
Olmesartan—Dermatitis—Simvastatin—atherosclerosis	6.82e-05	0.00107	CcSEcCtD
Olmesartan—Diarrhoea—Niacin—atherosclerosis	6.8e-05	0.00107	CcSEcCtD
Olmesartan—Headache—Simvastatin—atherosclerosis	6.78e-05	0.00107	CcSEcCtD
Olmesartan—Nausea—Ezetimibe—atherosclerosis	6.74e-05	0.00106	CcSEcCtD
Olmesartan—Diarrhoea—Pravastatin—atherosclerosis	6.7e-05	0.00105	CcSEcCtD
Olmesartan—Dizziness—Niacin—atherosclerosis	6.57e-05	0.00103	CcSEcCtD
Olmesartan—Dizziness—Pravastatin—atherosclerosis	6.47e-05	0.00102	CcSEcCtD
Olmesartan—ABCC2—liver—atherosclerosis	6.45e-05	0.0337	CbGeAlD
Olmesartan—Nausea—Simvastatin—atherosclerosis	6.43e-05	0.00101	CcSEcCtD
Olmesartan—Vomiting—Niacin—atherosclerosis	6.32e-05	0.000995	CcSEcCtD
Olmesartan—Rash—Niacin—atherosclerosis	6.27e-05	0.000987	CcSEcCtD
Olmesartan—Dermatitis—Niacin—atherosclerosis	6.26e-05	0.000986	CcSEcCtD
Olmesartan—Headache—Niacin—atherosclerosis	6.23e-05	0.00098	CcSEcCtD
Olmesartan—Vomiting—Pravastatin—atherosclerosis	6.22e-05	0.00098	CcSEcCtD
Olmesartan—Rash—Pravastatin—atherosclerosis	6.17e-05	0.000971	CcSEcCtD
Olmesartan—Dermatitis—Pravastatin—atherosclerosis	6.16e-05	0.00097	CcSEcCtD
Olmesartan—Headache—Pravastatin—atherosclerosis	6.13e-05	0.000965	CcSEcCtD
Olmesartan—Nausea—Niacin—atherosclerosis	5.9e-05	0.000929	CcSEcCtD
Olmesartan—Nausea—Pravastatin—atherosclerosis	5.81e-05	0.000915	CcSEcCtD
Olmesartan—Valsartan—ALB—atherosclerosis	5.79e-05	0.0207	CrCbGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	3.02e-05	0.0011	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CX3CL1—atherosclerosis	2.99e-05	0.00109	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	2.96e-05	0.00108	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HRH1—atherosclerosis	2.91e-05	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	2.91e-05	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	2.83e-05	0.00103	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CNR2—atherosclerosis	2.83e-05	0.00103	CbGpPWpGaD
Olmesartan—Losartan—ALB—atherosclerosis	2.83e-05	0.0101	CrCbGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.83e-05	0.00103	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	2.78e-05	0.00101	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.73e-05	0.000995	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.72e-05	0.000992	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LDLRAP1—atherosclerosis	2.7e-05	0.000983	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.63e-05	0.000961	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—atherosclerosis	2.62e-05	0.000956	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCG1—atherosclerosis	2.58e-05	0.000943	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—AGT—atherosclerosis	2.57e-05	0.000937	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLTP—atherosclerosis	2.53e-05	0.000925	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL3—atherosclerosis	2.44e-05	0.000889	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—FABP4—atherosclerosis	2.43e-05	0.000887	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LCAT—atherosclerosis	2.43e-05	0.000887	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR2—atherosclerosis	2.43e-05	0.000885	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—EDNRA—atherosclerosis	2.43e-05	0.000885	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—PLG—atherosclerosis	2.4e-05	0.000877	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOA4—atherosclerosis	2.39e-05	0.00087	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—F2—atherosclerosis	2.37e-05	0.000866	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—GHRL—atherosclerosis	2.36e-05	0.000863	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.35e-05	0.000857	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP7A1—atherosclerosis	2.34e-05	0.000855	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.33e-05	0.000851	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.32e-05	0.000846	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—CETP—atherosclerosis	2.29e-05	0.000837	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOA4—atherosclerosis	2.29e-05	0.000834	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	2.28e-05	0.000831	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.27e-05	0.000827	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.23e-05	0.000815	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.22e-05	0.000809	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR2—atherosclerosis	2.2e-05	0.000804	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDNRA—atherosclerosis	2.2e-05	0.000804	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCG8—atherosclerosis	2.2e-05	0.000802	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LTA4H—atherosclerosis	2.2e-05	0.000802	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	2.2e-05	0.000801	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.17e-05	0.000792	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP27A1—atherosclerosis	2.17e-05	0.00079	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—CETP—atherosclerosis	2.15e-05	0.000786	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—GHRL—atherosclerosis	2.15e-05	0.000783	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.13e-05	0.000778	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—APOB—atherosclerosis	2.12e-05	0.000775	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL2—atherosclerosis	2.12e-05	0.000772	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL4—atherosclerosis	2.11e-05	0.000769	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.08e-05	0.000759	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—KNG1—atherosclerosis	2.07e-05	0.000757	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLA2G2A—atherosclerosis	2.05e-05	0.000749	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOA2—atherosclerosis	2.05e-05	0.000749	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALOX5AP—atherosclerosis	2.05e-05	0.000749	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALOX15—atherosclerosis	2.05e-05	0.000749	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.05e-05	0.000748	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCG5—atherosclerosis	2.03e-05	0.00074	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.03e-05	0.000739	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.02e-05	0.000737	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOA2—atherosclerosis	1.97e-05	0.000718	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LPA—atherosclerosis	1.96e-05	0.000715	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.9e-05	0.000693	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—BGN—atherosclerosis	1.9e-05	0.000692	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KNG1—atherosclerosis	1.88e-05	0.000688	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.88e-05	0.000687	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—TGFB1—atherosclerosis	1.88e-05	0.000686	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOA5—atherosclerosis	1.88e-05	0.000685	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—UTS2—atherosclerosis	1.88e-05	0.000685	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.83e-05	0.000666	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.82e-05	0.000666	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLA2G1B—atherosclerosis	1.81e-05	0.00066	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASR—atherosclerosis	1.8e-05	0.000657	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CX3CR1—atherosclerosis	1.8e-05	0.000657	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.79e-05	0.000654	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.79e-05	0.000652	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.77e-05	0.000646	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.77e-05	0.000645	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CX3CL1—atherosclerosis	1.76e-05	0.000644	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—atherosclerosis	1.76e-05	0.000642	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—EDN1—atherosclerosis	1.75e-05	0.000638	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALOX5—atherosclerosis	1.75e-05	0.000637	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCG1—atherosclerosis	1.74e-05	0.000634	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCL5—atherosclerosis	1.73e-05	0.000633	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PLG—atherosclerosis	1.72e-05	0.000627	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.68e-05	0.000613	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CNR2—atherosclerosis	1.67e-05	0.000611	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL8—atherosclerosis	1.67e-05	0.00061	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MMP3—atherosclerosis	1.67e-05	0.000609	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	1.67e-05	0.000608	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCG—atherosclerosis	1.65e-05	0.000602	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—FABP4—atherosclerosis	1.63e-05	0.000596	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LCAT—atherosclerosis	1.63e-05	0.000596	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.61e-05	0.000589	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.61e-05	0.000589	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA4—atherosclerosis	1.6e-05	0.000585	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDN1—atherosclerosis	1.59e-05	0.000579	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.59e-05	0.000579	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL5—atherosclerosis	1.58e-05	0.000575	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP7A1—atherosclerosis	1.57e-05	0.000575	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NAMPT—atherosclerosis	1.57e-05	0.000571	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.56e-05	0.000568	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LIPC—atherosclerosis	1.56e-05	0.000568	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOC3—atherosclerosis	1.55e-05	0.000564	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LDLR—atherosclerosis	1.54e-05	0.000561	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOB—atherosclerosis	1.52e-05	0.000554	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CETP—atherosclerosis	1.5e-05	0.000548	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.5e-05	0.000548	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCG—atherosclerosis	1.5e-05	0.000547	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VWF—atherosclerosis	1.49e-05	0.000544	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.49e-05	0.000544	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOC3—atherosclerosis	1.48e-05	0.000541	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LDLR—atherosclerosis	1.47e-05	0.000538	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP27A1—atherosclerosis	1.46e-05	0.000531	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AGT—atherosclerosis	1.45e-05	0.00053	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL3—atherosclerosis	1.44e-05	0.000525	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SCARB1—atherosclerosis	1.44e-05	0.000525	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.43e-05	0.000523	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.43e-05	0.000521	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.4e-05	0.000511	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.4e-05	0.00051	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA2—atherosclerosis	1.38e-05	0.000503	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLA2G2A—atherosclerosis	1.38e-05	0.000503	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALOX5AP—atherosclerosis	1.38e-05	0.000503	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALOX15—atherosclerosis	1.38e-05	0.000503	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NCF1—atherosclerosis	1.38e-05	0.000503	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCG5—atherosclerosis	1.36e-05	0.000497	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.36e-05	0.000497	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMGCR—atherosclerosis	1.36e-05	0.000495	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—F2—atherosclerosis	1.34e-05	0.000489	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—atherosclerosis	1.33e-05	0.000486	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AGT—atherosclerosis	1.32e-05	0.000481	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPA—atherosclerosis	1.32e-05	0.00048	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDNRA—atherosclerosis	1.3e-05	0.000475	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR2—atherosclerosis	1.3e-05	0.000475	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CYBA—atherosclerosis	1.3e-05	0.000473	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CG—atherosclerosis	1.28e-05	0.000468	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.28e-05	0.000468	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BGN—atherosclerosis	1.27e-05	0.000465	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GHRL—atherosclerosis	1.27e-05	0.000463	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLAT—atherosclerosis	1.27e-05	0.000463	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PARP1—atherosclerosis	1.27e-05	0.000463	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.27e-05	0.000462	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA5—atherosclerosis	1.26e-05	0.00046	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.23e-05	0.000447	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.22e-05	0.000447	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—F2—atherosclerosis	1.22e-05	0.000444	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLA2G1B—atherosclerosis	1.21e-05	0.000443	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCA1—atherosclerosis	1.21e-05	0.000442	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.2e-05	0.000439	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.2e-05	0.000439	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.2e-05	0.000438	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.19e-05	0.000434	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.19e-05	0.000433	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALOX5—atherosclerosis	1.17e-05	0.000428	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CG—atherosclerosis	1.17e-05	0.000425	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.13e-05	0.000412	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KNG1—atherosclerosis	1.11e-05	0.000406	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—atherosclerosis	1.09e-05	0.000396	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.08e-05	0.000395	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLG—atherosclerosis	1.08e-05	0.000393	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NAMPT—atherosclerosis	1.05e-05	0.000384	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.05e-05	0.000382	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LIPC—atherosclerosis	1.05e-05	0.000382	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOC3—atherosclerosis	1.04e-05	0.000379	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMOX1—atherosclerosis	1.04e-05	0.000379	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LDLR—atherosclerosis	1.03e-05	0.000377	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SOCS3—atherosclerosis	1.02e-05	0.000373	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CETP—atherosclerosis	1.01e-05	0.000368	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOB—atherosclerosis	9.95e-06	0.000363	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP3—atherosclerosis	9.86e-06	0.00036	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF2—atherosclerosis	9.82e-06	0.000358	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTM1—atherosclerosis	9.68e-06	0.000353	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SCARB1—atherosclerosis	9.66e-06	0.000353	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOB—atherosclerosis	9.53e-06	0.000348	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—atherosclerosis	9.52e-06	0.000347	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LPL—atherosclerosis	9.5e-06	0.000347	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—atherosclerosis	9.45e-06	0.000345	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.41e-06	0.000343	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDN1—atherosclerosis	9.38e-06	0.000342	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL5—atherosclerosis	9.31e-06	0.00034	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GPX1—atherosclerosis	9.27e-06	0.000338	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMGCR—atherosclerosis	9.12e-06	0.000333	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LPL—atherosclerosis	9.1e-06	0.000332	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CD36—atherosclerosis	9.02e-06	0.000329	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—atherosclerosis	8.94e-06	0.000326	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCG—atherosclerosis	8.85e-06	0.000323	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SPP1—atherosclerosis	8.62e-06	0.000315	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—atherosclerosis	8.58e-06	0.000313	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—atherosclerosis	8.55e-06	0.000312	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARA—atherosclerosis	8.39e-06	0.000306	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.23e-06	0.0003	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCA1—atherosclerosis	8.13e-06	0.000297	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AGT—atherosclerosis	8.12e-06	0.000296	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDGFB—atherosclerosis	7.98e-06	0.000291	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOE—atherosclerosis	7.96e-06	0.00029	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAV1—atherosclerosis	7.89e-06	0.000288	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOA1—atherosclerosis	7.87e-06	0.000287	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGT—atherosclerosis	7.79e-06	0.000284	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LEP—atherosclerosis	7.63e-06	0.000278	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOE—atherosclerosis	7.63e-06	0.000278	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CAV1—atherosclerosis	7.56e-06	0.000276	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOA1—atherosclerosis	7.54e-06	0.000275	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ESR1—atherosclerosis	7.28e-06	0.000266	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2—atherosclerosis	7.19e-06	0.000263	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CG—atherosclerosis	7.18e-06	0.000262	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMOX1—atherosclerosis	6.98e-06	0.000255	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARG—atherosclerosis	6.93e-06	0.000253	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CG—atherosclerosis	6.88e-06	0.000251	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—INS—atherosclerosis	6.8e-06	0.000248	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOB—atherosclerosis	6.68e-06	0.000244	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAPK3—atherosclerosis	6.59e-06	0.000241	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—INS—atherosclerosis	6.52e-06	0.000238	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM1—atherosclerosis	6.5e-06	0.000237	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—atherosclerosis	6.41e-06	0.000234	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPL—atherosclerosis	6.38e-06	0.000233	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—atherosclerosis	6.3e-06	0.00023	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—atherosclerosis	6.23e-06	0.000228	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX1—atherosclerosis	6.23e-06	0.000227	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CD36—atherosclerosis	6.06e-06	0.000221	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SERPINE1—atherosclerosis	5.99e-06	0.000218	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—atherosclerosis	5.96e-06	0.000218	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—atherosclerosis	5.74e-06	0.00021	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—atherosclerosis	5.71e-06	0.000209	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARA—atherosclerosis	5.64e-06	0.000206	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AGT—atherosclerosis	5.46e-06	0.000199	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—atherosclerosis	5.45e-06	0.000199	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOE—atherosclerosis	5.35e-06	0.000195	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAV1—atherosclerosis	5.3e-06	0.000193	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA1—atherosclerosis	5.29e-06	0.000193	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—atherosclerosis	5.07e-06	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—atherosclerosis	4.9e-06	0.000179	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	4.83e-06	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—atherosclerosis	4.82e-06	0.000176	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARG—atherosclerosis	4.66e-06	0.00017	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—atherosclerosis	4.59e-06	0.000167	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—INS—atherosclerosis	4.57e-06	0.000167	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NFKB1—atherosclerosis	4.54e-06	0.000166	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK8—atherosclerosis	4.46e-06	0.000163	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—atherosclerosis	4.45e-06	0.000162	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—atherosclerosis	4.19e-06	0.000153	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—atherosclerosis	4.12e-06	0.00015	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—atherosclerosis	4.08e-06	0.000149	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—atherosclerosis	4.01e-06	0.000146	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK3—atherosclerosis	3.89e-06	0.000142	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—atherosclerosis	3.78e-06	0.000138	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—atherosclerosis	3.66e-06	0.000134	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—atherosclerosis	2.85e-06	0.000104	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—atherosclerosis	2.74e-06	0.0001	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—atherosclerosis	2.63e-06	9.59e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—atherosclerosis	1.84e-06	6.72e-05	CbGpPWpGaD
